However, Holler et al. demonstrated that when a mTOR inhibitor is combined with an AKT inhibitor (MK2206), significant radiosensitising effects may be observed in NSCLC cell lines [39]. This evidence concerns the gene MTOR and non-small cell lung carcinoma.